Psychedelics have shown promise in treating diverse mental health disorders, but exactly how they rewire the mind remains a mystery. A small 2022 study from Imperial College in London provides some answers. Patients with severe depression were given either psilocybin or a popular antidepressant (escitalopram). The researchers used functional magnetic resonance imaging to measure brain activity pre-dose and three weeks after. The results were enlightening:…
